NHS BOSS SIR SIMON STEVENS TO STEP DOWN Sir Simon Stevens is to step down as the head of NHS England and become a peer, the UK government has announced. After seven years in the role, Sir Stevens will leave on 31 July having overseen the COVID-19 vaccination rollout to all adults. Sir Stevens has previously been vocal about the […]
» Read more
ProductLife Group (PLG) has taken the next step in its evolution as a global leader in end-to-end regulatory compliance services. Just 6 months after the acquisition of the Vigilance and Medical Information group AxPharma, ProductLife Group has today announced the strategic acquisition of leading US regulatory drug development consultancy DSI. This allows PLG to expand in North America and reinforce […]
» Read more
The last time Sieglinde Schopf hugged Hannes, her husband of almost 50 years, was before he boarded a train to go skiing in Austria’s popular Alpine province of Tyrol last March. A few weeks later, in April, the 72-year-old, infected with coronavirus, died alone, hooked up to a hospital bed. “My entire world shattered into pieces,” says Schopf, who had […]
» Read more
Abbott today announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can […]
» Read more
Blood pressure-lowering medication can prevent serious cardiovascular conditions such as strokes, heart failure and heart attacks even in adults with normal blood pressure, according to new research published in The Lancet. Importantly, the study found the beneficial effects of treatment were similar regardless of the starting blood pressure level, in both people who had previously had a heart attack or […]
» Read more
As beauty brands grapple with minimizing environmental impact and resonating strongly with consumers, beauty brand Biossance says the two efforts share the same solutions. At Fairchild Media Group’s Sustainability Summit, Catherine Gore, president of Biossance, said unconventional sourcing alternatives are encoded in all of the brand’s touchpoints with suppliers, fellow brands and consumers alike. “We’ve always had an open-source policy […]
» Read more
Sometimes, socks aren’t enough to keep your feet warm inside the house, so slippers are a must. When it comes to picking out slippers for little ones, there are so many to choose from—but that doesn’t mean they’ll wear just any pair. When shopping for kids slippers, you’ll want to consider their favorite colors, patterns, and TV and movie characters. […]
» Read more
Last Friday, the Centers for Disease Control and Prevention (CDC) and the U.S. Food & Drug Administration (FDA) lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S. The temporary pause was due to reports of a serious condition called cerebral venous sinus thrombosis (CVST), which refers to blood clots in the brain's veins […]
» Read more
NEW YORK (Reuters Health) – A combination of ravidasvir and sofosbuvir appears to be an effective treatment for chronic hepatitis C virus (HCV) infection across a diverse pool of patients who took part in the first half of the single-arm STORM-C-1 trial underway in Malaysia and Thailand. “HCV affects predominantly vulnerable populations including people using drugs and HIV-coinfected people, who […]
» Read more
Congress has voted to temporarily extend a sweeping tool that has helped federal agents crack down on drugs chemically similar to fentanyl. The Senate on Thursday approved legislation extending until October an order that allows the federal government to classify so-called fentanyl analogues as Schedule I controlled substances. The drugs are generally foreign-made with a very close chemical makeup to […]
» Read more